Suqiao Bio appointed Ms. Chen Wei as Chief Financial Officer.

Guide: Ms. Chen has served as Vice President and CFO of Fosun Medical Group, leading the Group's financial management line.
Suqiao Bio today announced the appointment of Ms. Chen as the Company's Chief Financial Officer.
Ms. Chen will lay a solid foundation for the long-term development of Suqiao Bio's biomolecular CDMO business and open a new milestone for Suqiao Bio. Ms.
Ms. Chen has nearly 20 years of experience in listing, mergers and acquisitions, group-based integrated financial management and capital operation, during which time she has served many world-renowned pharmaceutical and medical group companies, with extensive experience in medical and pharmaceutical finance and investment management.
Ms. Chen Wei, Chief Financial Officer of Suqiao Bio, EMBA, China Europe Business School, "We are very pleased that Ms. Chen Wei has joined Suqiao Bio. "Ms. Chen has extensive experience in finance in the pharmaceutical sector and outstanding expertise in capital operations," said Dr. Wang Yongzhong, CEO of suqiao Bio,
.
Suqiao biology is in a period of rapid and high-quality development, at this critical moment, Ms. Chen's participation will further promote the development of Suqiao business. "I am very happy to be a member of the Suqiao creatures, " said Ms. Chen,
."
Suqiao Bio is a rare pure CDMO company in the field of biomoleculars, with a complete advanced technology platform, the core team has a wealth of Sino-American double newspaper and global development experience.
its pure CDMO business model, the fastest way to achieve the value of the customer, these are very much in the early or early innovation of the needs of new drug research and development enterprises, i am excited.
I look forward to working with Dr. Wang Yongzhong and all my colleagues to promote and achieve the company's strategic objectives.
"Before joining Suqiao, Ms. Chen served as Vice President and CFO of Fosun Medical Group, leading the Group's financial management line, promoting the financial system upgrading and process construction of the Group and more than 10 member units, and was responsible for the Group's capitalization projects and external financing; During the
, the financial team of the subsidiary companies (including 4 overseas subsidiaries) will be managed, the comprehensive financial management system of the Group should be established, the company's business planning and strategy will be launched, the company will be involved in organizing multiple mergers and acquisitions projects, and the completion of BPM (process management and informationization) projects, cost management promotion projects and the issuance of 400 million chinese tickets. Prior to
, Ms. Chen worked as a Senior Auditor at PricewaterhouseCoopers (Zhongtian) and as a financial management position at ACTARIS and a subsidiary of the Hong Kong TOM Group.
Ms. Chen holds a master's degree from Southwest University of Finance and Economics, an EMBA from China Europe International Business School, a certified public accountant, a certified asset appraiser, and other qualifications.
.